AbbVie Other Charges decreased by 90.6% to -$2.31B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 59.6%, from -$1.45B to -$2.31B. Over 4 years (FY 2021 to FY 2025), Other Charges shows a downward trend with a 23.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
hon_other_charges| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.66B | -$21.00M | -$216.00M | $776.00M | -$1.53B | $330.00M | -$2.02B | -$1.80B | -$1.41B | $95.00M | -$1.56B | -$586.00M | -$1.35B | -$1.16B | -$150.00M | -$1.45B | -$2.64B | -$503.00M | -$1.21B | -$2.31B |
| QoQ Change | — | +99.2% | -928.6% | +459.3% | -297.6% | +121.5% | -712.4% | +10.7% | +21.7% | +106.7% | <-999% | +62.3% | -129.5% | +13.8% | +87.1% | -863.3% | -82.6% | +80.9% | -140.6% | -90.6% |
| YoY Change | — | — | — | — | +42.3% | >999% | -835.6% | -332.5% | +7.9% | -71.2% | +23.0% | +67.5% | +4.7% | <-999% | +90.4% | -146.6% | -96.2% | +56.6% | -706.7% | -59.6% |